SCHEMBL29516981

SCHEMBL29516981

O=C(O)c1cncc(C2CC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.41
▸ HCAR2 Q8TDS4 3/20 0.41
▸ KDM4E B2RXH2 4/20 0.39
▸ NAPRT Q6XQN6 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ DGAT1 O75907 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ HIF1A Q16665 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RBP4 P02753 1/20 0.35
▸ ALOX15 P16050 3/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706074 0.88 CNR2 (0.41) KMOHCAR2KDM4ENAPRTPOLB
SCHEMBL31706867 0.79 DGAT2 (0.36) POLBALDH1A1HPGDHSD17B10
SCHEMBL69399 0.76 KDM4E (0.55) HCAR2KDM4ENAPRTPOLBKMT2A
SCHEMBL19280323 0.76 PIM1 (0.33) L3MBTL1
SCHEMBL15019902 0.73 KDM4E (0.59) KMOHCAR2KDM4EPOLBKMT2A
SCHEMBL30903051 0.73 KDM4E (0.59) KMOHCAR2KDM4EPOLBKMT2A
Lithium SCHEMBL29514614 0.72 KDM4E (0.57) KMOHCAR2KDM4EPOLBKMT2A
SCHEMBL21199945 0.72 ALOX15 (0.61) KMOHCAR2KDM4EPOLBSMN1; SMN2
Lithium Ion SCHEMBL31704471 0.72 CNR2 (0.40) POLBALDH1A1HPGDHSD17B10
SCHEMBL25135911 0.71 CNR2 (0.50) SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116056766-A Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof 富士胶片株式会社 2023-05-02 — — CN claimed
WO-2022025174-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF 富士フイルム株式会社 2022-02-03 — — WO claimed
US-12637435-B2 Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof FUJIFILM CORPORATION (JP) 2026-05-26 — — US disclosed
US-20230167074-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF FUJIFILM CORPORATION (JP) 2023-06-01 — — US disclosed
CN-116056766-A Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof 富士胶片株式会社 2023-05-02 — — CN disclosed
WO-2022025174-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF 富士フイルム株式会社 2022-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167074-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF DHRS9, DHODH, CBR1 KMO 759/4885HCAR2 726/4885KDM4E 2423/4885
US-12637435-B2 Nitrogen-containing heterocyclic compound or salt thereof, use thereof, and intermediate thereof CBR1, DHODH, CBR3 KMO 599/4885HCAR2 518/4885KDM4E 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback